<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39437308</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2047-2412</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>22</Day></PubDate></JournalIssue><Title>European heart journal. Cardiovascular Imaging</Title><ISOAbbreviation>Eur Heart J Cardiovasc Imaging</ISOAbbreviation></Journal><ArticleTitle>Echocardiographic Phenotype in Severe Aortic Stenosis With and Without Transthyretin Cardiac Amyloidosis: The AMY-TAVI Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">jeae263</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ehjci/jeae263</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">The relative apical sparing pattern of left ventricular (LV) longitudinal strain (RELAPS]&gt;1) has been described as a typical sign of cardiac amyloidosis (CA). The objective was to validate this pattern in concomitant CA and aortic stenosis (AS) and to identify new echocardiographic variables suggestive of CA in the presence of AS.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">324 consecutive patients (age 81.5±5.8 years, 51% women) with AS who underwent transcatheter aortic valve implantation (TAVI) were prospectively included. 2D-Speckle-tracking echocardiography was performed. Following TAVI, 99mTc-DPD-scintigraphy and protein electrophoresis were performed to screen for CA. 38 patients (11.7%) showed cardiac uptake in scintigraphy: 14 patients (4.3%) with grade 1, 13 (4%) with grade 2, and 11 (3.4%) with grade 3. Patients with grades 2 and 3 (AS-CA group) had more LV hypertrophy (LV mass index: 188 vs.172 g/m2, p=0.032), lower transvalvular aortic pressure gradient (p&lt;0.003), and higher prevalence of low-gradient AS (50% vs.19%, p=0.001), as well as greater diastolic and systolic dysfunction. Strain analysis was limited to 243 patients due to poor acoustic window and COVID-19 restrictions (81 lost: 79 in AS alone, 1 each in AS-DPD1 and AS-CA groups). RELAPS&gt;1 was more prevalent in AS-CA group (74% vs.44%, p=0.006). An echocardiographic prediction model (GRAM score) for CA in the presence of AS, that is more sensitive and specific than RELAPS&gt;1 alone, is proposed using the LV mass, maximum aortic gradient, and RELAPS&gt;1, in addition to age (AUC:0.85, 95%CI: 0.77-0.93).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">RELAPS&gt;1 is more prevalent in AS-CA but can occur in almost half of AS patients without CA, which reduces its value as a screening tool. A more sensitive and specific prediction score for CA in patients with severe AS is proposed.</AbstractText><CopyrightInformation>© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bastos-Fernandez</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7088-5858</Identifier><AffiliationInfo><Affiliation>Cardiology Department. University Clinical Hospital of Santiago de Compostela. Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Otero</LastName><ForeName>Diego</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-2810-3979</Identifier><AffiliationInfo><Affiliation>Cardiology Department. University Clinical Hospital of Santiago de Compostela. Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBERCV. Center for Biomedical Research in Cardiovascular Diseases Network. Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Pais</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiology Department. University Clinical Hospital of Santiago de Compostela. Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pubul-Nuñez</LastName><ForeName>Virginia</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Research Methods Group (RESMET), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neiro-Rey</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Cardiology Department. University Clinical Hospital of Santiago de Compostela. Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lado-Baleato</LastName><ForeName>Oscar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Research Methods Group (RESMET), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gude-Sampedro</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Depatment of Statistics. University Clinical Hospital of Santiago de Compostela. Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvarez-Barredo</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8545-8138</Identifier><AffiliationInfo><Affiliation>Cardiology Department. University Clinical Hospital of Santiago de Compostela. Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez-Salvado</LastName><ForeName>Violeta</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Cardiology Department. University Clinical Hospital of Santiago de Compostela. Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pena-Gil</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Cardiology Department. University Clinical Hospital of Santiago de Compostela. Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinon-Martinez</LastName><ForeName>Jesus</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiology Department. University Clinical Hospital of Santiago de Compostela. Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de la Fuente Rey</LastName><ForeName>Antía</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology Department. University Clinical Hospital of Santiago de Compostela. Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otero-Garcia</LastName><ForeName>Oscar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Cardiology Department. University Clinical Hospital of Santiago de Compostela. Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jimenez-Ramos</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Cardiology Department. University Clinical Hospital of Santiago de Compostela. Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia-Rodeja</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cardiology Department. University Clinical Hospital of Santiago de Compostela. Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tasende-Rey</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cardiology Department. University Clinical Hospital of Santiago de Compostela. Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz-Donate</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiology Department. University Clinical Hospital of Santiago de Compostela. Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanmartin-Pena</LastName><ForeName>Xoan Carlos</ForeName><Initials>XC</Initials><AffiliationInfo><Affiliation>Cardiology Department. University Clinical Hospital of Santiago de Compostela. Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez-Monzonis</LastName><ForeName>Amparo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology Department. University Clinical Hospital of Santiago de Compostela. Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez-Juanatey</LastName><ForeName>Jose R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Cardiology Department. University Clinical Hospital of Santiago de Compostela. Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBERCV. Center for Biomedical Research in Cardiovascular Diseases Network. Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Heart J Cardiovasc Imaging</MedlineTA><NlmUniqueID>101573788</NlmUniqueID><ISSNLinking>2047-2404</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aortic valve stenosis</Keyword><Keyword MajorTopicYN="N">Echocardiography</Keyword><Keyword MajorTopicYN="N">TAVI</Keyword><Keyword MajorTopicYN="N">Transthyretin Amyloidosis</Keyword><Keyword MajorTopicYN="N">strain</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>18</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>18</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>16</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39437308</ArticleId><ArticleId IdType="doi">10.1093/ehjci/jeae263</ArticleId><ArticleId IdType="pii">7831543</ArticleId></ArticleIdList></PubmedData></PubmedArticle>